Company / AR per Share
Axsome Therapeutics, Inc. AR per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$4.61
FY2025
5-year range
$1.00 / $4.61
FY2022-FY2025
Trend
+53.8%
vs FY2024
Sector context
#23 of 113
Health Care
What the data says
Axsome Therapeutics, Inc.'s ar per share of $4.61 is higher than 80% of companies in the Health Care sector (FY2025). AR per Share has increased for 3 consecutive years, from $1.00 in FY2022 to $4.61 in FY2025.
Based on SEC 10-K filings.
4.61 in FY2025 with a 3-year CAGR of +66.6%. Top quartile in the Health Care sector.
Improved from $2.18 to $4.61 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +66.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 113This company $4.61 Sector average $28.83
▼
-84.0% below sector average
Key checks
Key Insights
- Axsome Therapeutics, Inc.'s ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 53.8% year-over-year.
- Ranks #23 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.61 | +53.8% |
| FY2024 | $3.00 | +37.6% |
| FY2023 | $2.18 | +118.7% |
| FY2022 | $1.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026